Clinical In-Hospital Outcomes of Acute Myocardial Infarction in Patients With Hematological Malignancies

Figures

• 

  Figure 1. Flow chart Flow chart of the study selection process

• 

  Figure 2. Mortality incidence in hematological cancer Trends in mortality incidence in hematological cancer with acute myocardial infarction. The blue curve indicates acute myocardial infarction with underlying hematological malignancy (%). The orange curve indicates acute myocardial infarction without underlying hematological malignancy (%).

• 

  Figure 3. Mortality incidence in myeloid leukemia. Trends in mortality incidence in myeloid leukemia with acute myocardial infarction. The blue curve indicates myocardial infarction in myeloid leukemia (%). The orange curve indicates acute myocardial infarction without myeloid leukemia (%).

• 

  Figure 4. Mortality incidence in lymphocytic leukemia Trends in mortality incidence in lymphocytic leukemia with acute myocardial infarction. Blue curve indicates acute myocardial infarction with lymphocytic leukemia (%). Orange curve indicates acute myocardial infarction with lymphocytic leukemia (%).

• 

  Figure 5. Mortality incidence in multiple myeloma. Trends in mortality incidence in multiple myeloma with acute myocardial infarction. The blue curve indicates acute myocardial infarction with underlying multiple myeloma (%). The orange curve indicates acute myocardial infarction without underlying multiple myeloma (%).

• 

  Figure 6. Mortality incidence in lymphoma Trends in mortality incidence in lymphoma with acute myocardial infarction. The blue curve indicates myocardial infarction in lymphoma (%). The orange curve indicates acute myocardial infarction without lymphoma (%).

• 

  Figure 7. Cost of hospitalizations for hematological cancers Trends in the cost of hospitalizations for hematological cancers with myocardial infarction. Blue bars indicate acute myocardial infarction with underlying hematological neoplasms. Orange bars indicate acute myocardial infarction without underlying hematological neoplasms.

• 

  Figure 8. Cost of hospitalizations for myeloid leukemia Trends in the cost of hospitalizations for myeloid leukemia with myocardial infarction. Blue bars indicate acute myocardial infarction with underlying myeloid leukemia. Orange bars indicate acute myocardial infarction without underlying myeloid leukemia.

• 

  Figure 9. Cost of hospitalizations for lymphoma Trends in the cost of hospitalizations for lymphoma with myocardial infarction. Blue bars indicate the prevalence of myocardial infarction with underlying lymphoma. Orange bars indicate the prevalence of myocardial infarction without underlying lymphoma.

• 

  Figure 10. Cost of hospitalizations for multiple myeloma Trends in the cost of hospitalizations for multiple myeloma with myocardial infarction. Blue bars indicate acute myocardial infarction with underlying multiple myeloma. Orange bars indicate acute myocardial infarction without underlying multiple myeloma.

• 

  Figure 11. Cost of hospitalizations for lymphocytic leukemia. Trends in Cost of hospitalizations for lymphocytic leukemia with myocardial infarction. Blue bars indicate acute myocardial infarction with lymphocytic leukemia (%). Orange bars indicate acute myocardial infarction with lymphocytic leukemia (%).